E. Pope

发表

Prospective evaluation of changes in computed cranial tomography in patients with small cell lung carcinoma treated with chemotherapy and prophylactic cranial irradiation.

C. Spurr, B. Powell, J. Cruz, 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Single agent vincristine by infusion in refractory multiple myeloma.

C. Spurr, L. Case, H. Muss, 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Improved tolerance of vincristine by glutamic acid

C. Spurr, L. Case, H. Muss, 2004, Journal of Neuro-Oncology.

Lack of potentiation of vincristine‐induced neurotoxicity by VP‐16–213

C. Spurr, H. Muss, M. Cooper, 1983, American journal of clinical oncology.

Clinical trial of pyridoxine to reduce vincristine neurotoxicity

C. Spurr, J. Atkins, H. Muss, 2005, Journal of Neuro-Oncology.

Clinical trial of folinic acid to reduce vincristine neurotoxicity

L. Case, P. Zekan, M. Cooper, 2004, Cancer Chemotherapy and Pharmacology.

Sequential hemibody irradiation integrated into a chemotherapy-local radiotherapy program for limited disease small cell lung cancer.

L. Case, H. Muss, R. Choplin, 1986, International journal of radiation oncology, biology, physics.

Sequential hemibody and local irradiation with combination chemotherapy for small cell lung carcinoma: a preliminary analysis.

J. Atkins, R. Choplin, C. Scarantino, 1985, International journal of radiation oncology, biology, physics.

Phase II study of vincristine infusion in refractory small cell carcinoma of the lung

C. Spurr, D. Jackson, J. McCulloch, 1985, American journal of clinical oncology.

High‐dose cyclophosphamide and 5‐fluorouracil versus vincristine, doxorubicin, and cyclophosphamide in advanced carcinoma of the breast: A phase III study of the piedmont oncology association (POA)

C. Spurr, L. Case, H. Muss, 1984, Cancer.

Vincristine, doxorubicin, and cyclophosphamide versus low‐dose intravenous cyclophosphamide, methotrexate, and 5‐fluorouracil in advanced breast cancer. A randomized trial of the piedmont oncology association

C. Spurr, H. Muss, M. Cooper, 1982, Cancer.

High-dose cyclophosphamide and fluorouracil (CF) versus vincristine (V), doxorubicin (A), and cyclophosphamide (C) as first line therapy for advanced breast carcinoma

H. Muss, P. Zekan, E. Pope, 1982 .